AXIOGENES Stock

Stocks

End-of-day quote Xetra Other stock markets
- ^EUR	-

15-07-14	Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	BU
12-12-04	AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	BU
11-10-10	AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	BU

15-07-16

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-1.03%	+5.24%	+2.94%	+9.41%	50.25B
REVOLUTION MEDICINES, INC.	+0.25%	+1.70%	+419.39%	+621.71%	40.39B
IQVIA HOLDINGS INC.	+1.10%	+7.77%	+28.18%	-3.96%	34.38B
BEONE MEDICINES AG	-0.16%	+8.42%	+28.20%	+63.00%	34.4B
CELLTRION, INC.	+1.31%	-0.56%	+5.12%	+33.90%	26.32B
ASCENDIS PHARMA A/S	-0.35%	+0.09%	-	-	16.64B
MEDPACE HOLDINGS, INC.	-3.33%	+3.15%	+71.30%	+131.94%	16.14B
EUROFINS SCIENTIFIC SE	+0.32%	+0.53%	+14.33%	+21.47%	13.71B
IONIS PHARMACEUTICALS, INC.	+3.79%	+8.88%	+106.63%	+106.63%	13.75B
Average	+0.21%	+4.48%	+84.51%	+123.01%	27.33B
Weighted average by Cap.	+0.09%	+5.06%	+95.81%	+141.26%

Employees

Sector